Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Drugs

Breakdown of FDAAA Completed Pediatric Studies

   

Breakdown of studies completed between September 27, 2007 and November 18, 2013

Type of StudyBPCABPCA + PREAPREATotal
 Efficacy/Safety4531201277
 PK/Safety9402069
 PK/PD148931
 Safety642535
 Other2104557
 Total7693300469

 

  • Total number of studies completed under BPCA and PREA pursuant to FDAAA: 469

  • Total number of patients in completed FDAAA studies: 178,425

    • 23,628 in BPCA studies

    • 32,839 in CDER PREA studies

    • 121,958 in CBER PREA studies (Vaccines and Blood Products)

 

Page Last Updated: 10/05/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English